Retraction Note to: Gene Therapy https://doi.org/10.1038/s41434-020-0145-9, published online 14 May 2020
The Editor-in-Chief has retracted this article. After publication, concerns were raised regarding similarities in some of the images presented in the figures, specifically:
-
In Fig. 2A, the SH-SY5Y rClone30-RFP and rAnh-RFP images appear to share a highly similar feature.
-
In Fig. 4A, DAPI HepG2 panels rClone30 and rClone30-Anh(HN), Normal MDA-MB-231 panels rClone30 and rClone30-Anh(HN), and Normal A549 panels rClone30-Anh(F) and rAnh appear to overlap.
-
In Fig. 6A, some of the tumours exhibit similar features.
-
In Supplementary Fig. 2B, H22 DAPI panels rClone30-Anh(F) and rClone30-Anh(HN-F) appear to overlap.
The authors have stated that the original data are no longer available. Due to the high number of image concerns, the Editor-in-Chief no longer has confidence in the presented data.
Tianyan Liu, Qingzhong Yu and Deshan Li do not agree to this retraction. Guangchao Sui agrees to this retraction. Yu Zhang, Yukai Cao, Shan Jiang, Rui Sun, Jiechao Yin, Zhenqiu Gao, Guiping Ren, Zhenzhong Wang, Xu Sun, Wenying Sun and Wei Xiao have not responded to any correspondence from the editor or publisher about this retraction.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liu, T., Zhang, Y., Cao, Y. et al. Retraction Note: Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses. Gene Ther 31, 436 (2024). https://doi.org/10.1038/s41434-024-00459-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41434-024-00459-9
